128 related articles for article (PubMed ID: 38367602)
1. Roles of lysophosphatidic acid (LPA) receptor-mediated signaling in cellular functions modulated by endothelial cells in pancreatic cancer cells under hypoxic conditions.
Takai M; Yashiro N; Hara K; Amano Y; Yamamoto M; Tsujiuchi T
Pathol Res Pract; 2024 Mar; 255():155192. PubMed ID: 38367602
[TBL] [Abstract][Full Text] [Related]
2. Effects of LPA receptor-mediated signaling on the modulation of cellular functions of pancreatic cancer cells cultured in fibroblast supernatants under hypoxic conditions.
Takai M; Okuda A; Amano Y; Yashiro N; Hara K; Yamamoto M; Tsujiuchi T
J Bioenerg Biomembr; 2023 Jun; 55(3):169-177. PubMed ID: 37219648
[TBL] [Abstract][Full Text] [Related]
3. LPA receptor-mediated signaling regulates cell motility and survival to anticancer drug of pancreatic cancer cells under glucose-deprived and hypoxic conditions.
Takai M; Takauchi M; Kuribayashi M; Tsujiuchi T
Biochem Biophys Res Commun; 2023 Jun; 661():21-27. PubMed ID: 37084489
[TBL] [Abstract][Full Text] [Related]
4. Lysophosphatidic acid signaling via LPA
Fukushima K; Takahashi K; Yamasaki E; Onishi Y; Fukushima N; Honoki K; Tsujiuchi T
Exp Cell Res; 2017 Mar; 352(1):139-145. PubMed ID: 28189636
[TBL] [Abstract][Full Text] [Related]
5. Roles of endothelial cells in the regulation of cell motility via lysophosphatidic acid receptor-2 (LPA
Minami K; Ueda N; Ishimoto K; Kurisu R; Takamoto M; Ikeda H; Tsujiuchi T
Exp Mol Pathol; 2021 Feb; 118():104596. PubMed ID: 33347862
[TBL] [Abstract][Full Text] [Related]
6. LPA signaling through LPA receptors regulates cellular functions of endothelial cells treated with anticancer drugs.
Mori S; Araki M; Ishii S; Hirane M; Fukushima K; Tomimatsu A; Takahashi K; Fukushima N; Tsujiuchi T
Mol Cell Biochem; 2015 Oct; 408(1-2):147-54. PubMed ID: 26116018
[TBL] [Abstract][Full Text] [Related]
7. LPA
Minami K; Ueda N; Ishimoto K; Tsujiuchi T
Exp Cell Res; 2020 Mar; 388(1):111813. PubMed ID: 31904382
[TBL] [Abstract][Full Text] [Related]
8. Diverse effects of LPA4, LPA5 and LPA6 on the activation of tumor progression in pancreatic cancer cells.
Ishii S; Hirane M; Fukushima K; Tomimatsu A; Fukushima N; Tsujiuchi T
Biochem Biophys Res Commun; 2015 May; 461(1):59-64. PubMed ID: 25849892
[TBL] [Abstract][Full Text] [Related]
9. Lysophosphatidic acid (LPA) receptor-mediated signaling regulates hypoxia-induced biological functions of lymphatic endothelial cells.
Yamamoto M; Takai M; Yashiro N; Hayasaka H; Tsujiuchi T
Biochem Biophys Res Commun; 2024 Jun; 715():149982. PubMed ID: 38676998
[TBL] [Abstract][Full Text] [Related]
10. Roles of lysophosphatidic acid (LPA) receptor-2 (LPA
Okuda A; Takai M; Kurisu R; Takamoto M; Ikeda H; Tsujiuchi T
Int J Radiat Biol; 2023; 99(12):1925-1933. PubMed ID: 37523658
[TBL] [Abstract][Full Text] [Related]
11. Lysophosphatidic acid stimulates activation of focal adhesion kinase and paxillin and promotes cell motility, via LPA1-3, in human pancreatic cancer.
Liao Y; Mu G; Zhang L; Zhou W; Zhang J; Yu H
Dig Dis Sci; 2013 Dec; 58(12):3524-33. PubMed ID: 24061591
[TBL] [Abstract][Full Text] [Related]
12. Promotion of cell-invasive activity through the induction of LPA receptor-1 in pancreatic cancer cells.
Fukushima K; Otagaki S; Takahashi K; Minami K; Ishimoto K; Fukushima N; Honoki K; Tsujiuchi T
J Recept Signal Transduct Res; 2018 Aug; 38(4):367-371. PubMed ID: 30396320
[TBL] [Abstract][Full Text] [Related]
13. Modulation of chemoresistance by lysophosphatidic acid (LPA) signaling through LPA
Minami K; Ueda N; Maeda H; Ishimoto K; Otagaki S; Tsujiuchi T
Biochem Biophys Res Commun; 2019 Sep; 517(2):359-363. PubMed ID: 31362892
[TBL] [Abstract][Full Text] [Related]
14. The gep proto-oncogene Gα13 mediates lysophosphatidic acid-mediated migration of pancreatic cancer cells.
Gardner JA; Ha JH; Jayaraman M; Dhanasekaran DN
Pancreas; 2013 Jul; 42(5):819-28. PubMed ID: 23508014
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of pancreatic cancer cell migration with multiple parameters in vitro by using an optical real-time cell mobility assay device.
Yamauchi A; Yamamura M; Katase N; Itadani M; Okada N; Kobiki K; Nakamura M; Yamaguchi Y; Kuribayashi F
BMC Cancer; 2017 Mar; 17(1):234. PubMed ID: 28359316
[TBL] [Abstract][Full Text] [Related]
16. Involvement of oncogenic K-ras on cell migration stimulated by lysophosphatidic acid receptor-2 in pancreatic cancer cells.
Yoshikawa K; Tanabe E; Shibata A; Inoue S; Kitayoshi M; Okimoto S; Fukushima N; Tsujiuchi T
Exp Cell Res; 2013 Feb; 319(3):105-12. PubMed ID: 23041208
[TBL] [Abstract][Full Text] [Related]
17. Negative regulation of cell motile and invasive activities by lysophosphatidic acid receptor-3 in colon cancer HCT116 cells.
Fukui R; Tanabe E; Kitayoshi M; Yoshikawa K; Fukushima N; Tsujiuchi T
Tumour Biol; 2012 Dec; 33(6):1899-905. PubMed ID: 22763559
[TBL] [Abstract][Full Text] [Related]
18. Effects of lysophosphatidic acid (LPA) signaling via LPA receptors on cellular functions associated with ATP reduction in osteosarcoma cells treated with ethidium bromide.
Kurisu R; Takamoto M; Minami K; Ueda N; Yamada M; Shima N; Otani T; Sakai Y; Kondo D; Tsujiuchi T
J Bioenerg Biomembr; 2022 Apr; 54(2):109-117. PubMed ID: 35260987
[TBL] [Abstract][Full Text] [Related]
19. Opposite roles of LPA1 and LPA3 on cell motile and invasive activities of pancreatic cancer cells.
Kato K; Yoshikawa K; Tanabe E; Kitayoshi M; Fukui R; Fukushima N; Tsujiuchi T
Tumour Biol; 2012 Oct; 33(5):1739-44. PubMed ID: 22678979
[TBL] [Abstract][Full Text] [Related]
20. Involvement of LPA signaling via LPA receptor-2 in the promotion of malignant properties in osteosarcoma cells.
Takahashi K; Fukushima K; Tanaka K; Minami K; Ishimoto K; Otagaki S; Fukushima N; Honoki K; Tsujiuchi T
Exp Cell Res; 2018 Aug; 369(2):316-324. PubMed ID: 29859140
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]